TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size
- PMID: 41862649
- DOI: 10.1038/s41590-026-02458-x
TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size
Abstract
Immune interventions toward an HIV cure have focused on rejuvenating adaptive immune responses. Herein we provide a framework that features epigenetic programming of myeloid and CD4+ T cells as a major mechanism that promotes decay of the HIV reservoir. Coordinate regulation of gene expression and chromatin accessibility of pathways of innate antiviral immunity was associated with decay of cell-associated viral DNA (CA-vDNA) following analytical treatment interruption in simian immunodeficiency virus-infected rhesus macaques (RMs) treated with anti-IL-10 and anti-PD-1. TGF-β/SMAD signaling in a subset of combo-treated CA-vDNAhi RMs, suppressed this antiviral activity through histone deacetylases, reducing chromatin accessibility of interferon regulatory factors (IRFs) and STATs. Addition of HDAC inhibitors in vitro restored antiviral response in the presence of TGF-β. Induction of IL-6 in CA-vDNAlo RMs amplified the antiviral network through IRF9. We identified an overlapping molecular cascade in HIV elite controllers, who maintain small HIV reservoirs without antiviral treatment. These data provide insights into strategies for HIV cure interventions.
© 2026. The Author(s).
Conflict of interest statement
Competing interests: G.R., E.R., C.V.P., G.W., L.M., D.M.G., B.J.H. and D.J.H. are employed by and/or have financial interests in Merck & Co. The remaining authors declare no competing interests.
Update of
-
TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size.Res Sq [Preprint]. 2025 Mar 19:rs.3.rs-5626892. doi: 10.21203/rs.3.rs-5626892/v1. Res Sq. 2025. Update in: Nat Immunol. 2026 Mar 20. doi: 10.1038/s41590-026-02458-x. PMID: 40166014 Free PMC article. Updated. Preprint.
References
-
- van der Heijden, W. A. et al. Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells. JCI Insight 9, a022236 (2021).
Grants and funding
- R01AI179476/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- R37AI141258/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- UM1AI164561/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- P01AI178376/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
LinkOut - more resources
Full Text Sources
Research Materials
